A group aiming to 'end male violence' hope the garden will become a safe space for women.
Students at Greenwich University, where Ms Nessa studied, established the Sabina Project to "use the law to end male violence".Miss Motala hopes Saturday's unveiling and the walk will raise awareness about the issue, while also supporting various charities that help victims of domestic violence."The garden honours the legacy of Sabina.The group is hoping to raise money through donations, refreshments and face painting.
The group's president hopes the garden will be a place for women to use, particularly those connected with the university.
日本 最新ニュース, 日本 見出し
Similar News:他のニュース ソースから収集した、これに似たニュース記事を読むこともできます。
A multicenter, double-blind, randomized, parallel-group, placebo-controlled study to evaluate the efficacy and safety of camostat mesilate in patients with COVID-19 (CANDLE study) - BMC MedicineBackground In vitro drug screening studies have indicated that camostat mesilate (FOY-305) may prevent SARS-CoV-2 infection into human airway epithelial cells. This study was conducted to investigate whether camostat mesilate is an effective treatment for SARS-CoV-2 infection (COVID-19). Methods This was a multicenter, double-blind, randomized, parallel-group, placebo-controlled study. Patients were enrolled if they were admitted to a hospital within 5 days of onset of COVID-19 symptoms or within 5 days of a positive test for asymptomatic patients. Severe cases (e.g., those requiring oxygenation/ventilation) were excluded. Patients were enrolled, randomized, and allocated to each group using an interactive web response system. Randomization was performed using a minimization method with the factors medical institution, age, and underlying diseases (chronic respiratory disease, chronic kidney disease, diabetes mellitus, hypertension, cardiovascular diseases, and obesity). The patients, investigators/subinvestigators, study coordinators, and other study personnel were blinded throughout the study. Patients were administered camostat mesilate (600 mg qid; four to eight times higher than the clinical doses in Japan) or placebo for up to 14 days. The primary efficacy endpoint was the time to the first two consecutive negative tests for SARS-CoV-2. Results One-hundred fifty-five patients were randomized to receive camostat mesilate (n = 78) or placebo (n = 77). The median time to the first test was 11.0 days (95% confidence interval [CI]: 9.0–12.0) in the camostat mesilate group and 11.0 days (95% CI: 10.0–13.0) in the placebo group. Conversion to negative viral status by day 14 was observed in 45 of 74 patients (60.8%) in the camostat mesilate group and 47 of 74 patients (63.5%) in the placebo group. The primary (Bayesian) and secondary (frequentist) analyses found no significant differences in the primary endpoint between the two groups. No additional safety concerns be
続きを読む »
Facebook group give out heaps of essentials through pop-up foodbankA Watford Facebook group gave away heaps of food and other essentials last week as they organised their first foodbank event.
続きを読む »
Preston group hosting series of events to mark Black History MonthDominoes at Jalgos Pic: Joseph Gudgeon Preston Black History Group is hosting a series of events to mark Black History Month this October. The group is m
続きを読む »
Arsenal Invincibles using new WhatsApp group chat to send messages to ill fanRay Parlour has revealed to talkSPORT how he is part of an Invincibles WhatsApp group and the Arsenal legends are planning to hold a reunion later this year. There appears to still be plenty of ban…
続きを読む »
Powerful group of cross-party MPs demands chancellor brings forward full economic forecast and budgetA powerful group of cross-party MPs has demanded the chancellor release a full economic forecast by the end of October - a month earlier than planned.
続きを読む »
Independent Yorkshire brewery saved by group of beer-loving local businessmenA brewery which holds a significant place in Yorkshire’s brewing history has been saved by a group of local businessmen.
続きを読む »